RUTH GUZMAN: Open Payments
NPI 1346960556 · OSWEGO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,123 in 64 payments from 17 companies in 2025. Trend: 2023 $1,100 · 2024 $879 · 2025 $1,123
Food & beverage: $1,123
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $360 |
| AstraZeneca Pharmaceuticals LP | 11 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $104 |
| PFIZER INC. | 4 | $73 |
| Exact Sciences Corporation | 3 | $58 |
| Novo Nordisk Inc | 3 | $57 |
| Neurocrine BioSciences, Inc. | 2 | $47 |
| Lilly USA, LLC | 2 | $43 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| Corium, LLC | 1 | $28 |
Products named: VRAYLAR, UBRELVY, Kerendia, AIRSUPRA, The Cologuard Plus Collection Kit, QULIPTA, NURTEC ODT, BREZTRI.
Industry payments across NY — which companies pay providers there.
